Skip to main content

Table 2 Autoantibody profile of patients with systemic lupus erythematosus grouped according to their psychiatric symptoms

From: Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies

Autoantibodies

Group Aa (n = 17) No. (%)

Group Ba (n = 34) No. (%)

AECA IgGb

11 (64.7)

10 (29.4)

Anti-GFAP IgG

2 (11.7)

6 (17.6)

Anti-Ro IgG

8 (47)

15 (44.1)

Anti-Ro52 IgG

6 (35.3)

6 (17.6)

Anti-La IgG

5 (31.2)c

9 (26.4)

Anti-dsDNA IgG

9 (52.9)

19 (55.9)

Anti-nucleosome IgG

12 (70.6)

27 (79.4)

Anti-CL IgG

3 (17.6)

4 (11.7)

Anti-CL IgM

2 (11.8)

8 (23.5)

Anti-β2-GPI IgG

3 (17.6)

5 (14.7)

Anti-β2-GPI IgM

3 (23)

7 (28)

Anti-P IgG

2 (11.8)

2 (5.9)

  1. aGroup A, patients with mood disorders and psychosis; group B, patients without psychiatric manifestations other than anxiety. bP = 0.03 on the χ2 test; differences between groups A and B in other comparisons were not statistically significant. cMeasured in 16 of 17 patients. AECA, anti-endothelial-cell antibodies; β2-GPI, β2 glycoprotein I; CL, cardiolipin; GFAP, glial fibrillar acidic protein; P, ribosomal P protein.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us